Holly Kramer

24.1k total citations · 1 hit paper
290 papers, 10.1k citations indexed

About

Holly Kramer is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Holly Kramer has authored 290 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Nephrology, 88 papers in Cardiology and Cardiovascular Medicine and 42 papers in Surgery. Recurrent topics in Holly Kramer's work include Chronic Kidney Disease and Diabetes (71 papers), Blood Pressure and Hypertension Studies (54 papers) and Dialysis and Renal Disease Management (45 papers). Holly Kramer is often cited by papers focused on Chronic Kidney Disease and Diabetes (71 papers), Blood Pressure and Hypertension Studies (54 papers) and Dialysis and Renal Disease Management (45 papers). Holly Kramer collaborates with scholars based in United States, Germany and Jamaica. Holly Kramer's co-authors include Richard Cooper, Amy Luke, Guichan Cao, Gary C. Curhan, Ramón Durazo-Arvizú, A. Bidani, David A. Shoham, Michael G. Shlipak, Birgitta Stegmayr and Simona Giampaoli and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Circulation.

In The Last Decade

Holly Kramer

284 papers receiving 9.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypertension Treatment and Control in Five European Countries, Canada, and the United States

2003 838 citations Richard Cooper, Holly Kramer et al. profile →

Peers

Countries citing papers authored by Holly Kramer

Since Specialization

Citations

This map shows the geographic impact of Holly Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Kramer more than expected).

Fields of papers citing papers by Holly Kramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Kramer. The network helps show where Holly Kramer may publish in the future.

Co-authorship network of co-authors of Holly Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Kramer. A scholar is included among the top collaborators of Holly Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Kramer. Holly Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2025 ·Kidney International ·Alberto Ortíz, María José Guerra Palmero, Juliana C.N. Chan, (unknown), Holly Kramer, Susanne B. Nicholas, Meda E. Pavkov, Christoph Wanner, Leslie P. Wong, Michael Cheung, Jennifer King, Morgan E. Grams, Michel Jadoul, Katherine R. Tuttle, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
2	Association of Questionnaire‐Assessed Fall Risk With Uncontrolled Blood Pressure and Therapeutic Inertia Among Older Adults 2024 ·Journal of Clinical Hypertension ·(unknown), Talar Markossian, (unknown), (unknown), Holly Kramer	1
3	Racial Differences and Contributory Cardiovascular and Non-Cardiovascular Risk Factors Towards Chronic Kidney Disease Progression 2023 ·Vascular Health and Risk Management ·Yuni Choi, David R. Jacobs, Holly Kramer, Gautam R. Shroff, Alex R. Chang, Daniel Duprez	5
4	Age and Comorbidities Are Associated With Therapeutic Inertia Among Older Adults With Uncontrolled Blood Pressure 2023 ·American Journal of Hypertension ·(unknown), Talar Markossian, (unknown), M. Samie Tootooni, Gregory Wozniak, Michael Rakotz, Holly Kramer	6
5	Medical Nutrition Therapy for Chronic Kidney Disease: Low Access and Utilization 2023 ·PubMed ·(unknown), Joanne Kouba, Elizabeth Yakes Jimenez, Holly Kramer	3
6	Blood pressure measurement and blood pressure control in Veterans Affairs medical centers 2023 ·Journal of Clinical Hypertension ·(unknown), Ashley M. Hughes, Zhiping Huo, Frances M. Weaver, Kevin T. Stroupe, Elizabeth Tarlov, Holly Kramer	2
7	Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort 2022 ·Journal of the American Heart Association ·Yuni Choi, David R. Jacobs, Gautam R. Shroff, Holly Kramer, Alex R. Chang, Daniel Duprez	11
8	Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society 2022 ·Obesity ·Allon N. Friedman, Philip R. Schauer, Srinivasan Beddhu, Holly Kramer, Carel W. le Roux, Jonathan Q. Purnell, (unknown), Katherine R. Tuttle, Ania M. Jastreboff, Lee M. Kaplan	3
9	A Mobile App to Support Self-management of Chronic Kidney Disease: Development Study 2021 ·JMIR Human Factors ·Talar Markossian, (unknown), (unknown), Bella Etingen, François Modave, (unknown), Holly Kramer	19
10	Association of Overactive Bladder With Hypertension and Blood Pressure Control: The Multi-Ethnic Study of Atherosclerosis (MESA) 2021 ·American Journal of Hypertension ·(unknown), Kiang Liu, Erin D. Michos, Michael P. Bancks, Linda Brubaker, Talar Markossian, Ramón Durazo-Arvizú, Holly Kramer	12
11	Lower Urinary Tract Symptoms Should Be Queried When Initiating Sodium Glucose Co-Transporter 2 Inhibitors 2021 ·Kidney360 ·(unknown), Holly Kramer	14
12	Racial differences in urinary incontinence prevalence and associated bother: the Multi-Ethnic Study of Atherosclerosis 2020 ·American Journal of Obstetrics and Gynecology ·(unknown), Kiang Liu, Erin D. Michos, Linda Brubaker, Talar Markossian, Michael P. Bancks, Holly Kramer	11
13	Statin use among Veterans with dialysis‐dependent chronic kidney disease 2019 ·Hemodialysis International ·Talar Markossian, Holly Kramer, (unknown), Ivan Pacold, David J. Leehey, Zhiping Huo, Julia Schneider, (unknown), Kevin T. Stroupe	3
14	Low statin use in nondialysis-dependent chronic kidney disease in the absence of clinical atherosclerotic cardiovascular disease or diabetes 2019 ·Clinical Kidney Journal ·Talar Markossian, Holly Kramer, (unknown), Ivan Pacold, David J. Leehey, Zhiping Huo, Julia Schneider, (unknown), Kevin T. Stroupe	3
15	Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT 2018 ·Journal of the American Heart Association ·Srinivasan Beddhu, Glenn M. Chertow, Tom Greene, Paul K. Whelton, Walter T. Ambrosius, Alfred K. Cheung, Jeffrey A. Cutler, Lawrence J. Fine, Robert E. Boucher, Guo Wei, Chong Zhang, Holly Kramer, Adam P. Bress, Paul L. Kimmel, Suzanne Oparil, Cora E. Lewis, Mahboob Rahman, William C. Cushman	70
16	Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline 2018 ·Circulation ·Adam P. Bress, Lisandro D. Colantonio, Richard Cooper, Holly Kramer, John N. Booth, Michelle C. Odden, Kirsten Bibbins‐Domingo, Daichi Shimbo, Paul K. Whelton, Emily B. Levitan, George Howard, Brandon K. Bellows, Dawn Kleindorfer, Monika M. Safford, Paul Muntner, Andrew E. Moran	33
17	Increasing Mortality in Adults With Diabetes and Low Estimated Glomerular Filtration Rate in the Absence of Albuminuria 2018 ·Diabetes Care ·Holly Kramer, Robert E. Boucher, David J. Leehey, Linda F. Fried, Guo Wei, Tom Greene, Sylvia E. Rosas, Richard Cooper, Guichan Cao, Srinivasan Beddhu	43
18	Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States 2017 ·Circulation ·Adam P. Bress, Holly Kramer, Rasha Khatib, Srinivasan Beddhu, Alfred K. Cheung, Rachel Hess, Vinod Bansal, Guichan Cao, Jerry Yee, Andrew E. Moran, Ramón Durazo-Arvizú, Paul Muntner, Richard Cooper	76
19	Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures 2017 ·BMC Nephrology ·Christina Small, Holly Kramer, Karen A. Griffin, Kavitha Vellanki, David J. Leehey, Vinod Bansal, Talar Markossian	20
20	Is There a Reverse J-Shaped Association Between 25-Hydroxyvitamin D and All-Cause Mortality? Results from the U.S. Nationally Representative NHANES 2013 ·The Journal of Clinical Endocrinology & Metabolism ·Christopher T. Sempos, Ramón Durazo-Arvizú, Bess Dawson‐Hughes, Elizabeth A Yetley, Anne C. Looker, Rosemary L. Schleicher, Guichan Cao, Vicki L. Burt, Holly Kramer, Regan L Bailey, Johanna Dwyer, Xinli Zhang, Jaime Gahche, Paul M. Coates, Mary Frances Picciano	117

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact